Pomanda estimates the enterprise value of PHARMA MEDICO LIMITED at £867.7k based on a Turnover of £2m and 0.42x industry multiple (adjusted for size and gross margin).
pharma medico limitedEstimated Valuation
£282.4k
Pomanda estimates the enterprise value of PHARMA MEDICO LIMITED at £282.4k based on an EBITDA of £71.5k and a 3.95x industry multiple (adjusted for size and gross margin).
pharma medico limitedEstimated Valuation
£31.6k
Pomanda estimates the enterprise value of PHARMA MEDICO LIMITED at £31.6k based on Net Assets of £14.5k and 2.19x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Pharma Medico LimitedOverview
Pharma Medico Limited is a live company located in bristol, BS1 6FL with a Companies House number of 08383003. It operates in the wholesale of perfume and cosmetics sector, SIC Code 46450. Founded in January 2013, it's largest shareholder is
pharma medico uk ltd
with a 100% stake. Pharma Medico Limited is a established,
small sized company, Pomanda has estimated its turnover at
£2m with
declining
growth in recent years.
Pomanda's financial health check has awarded Pharma Medico Limited a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 0 measures and has 8 areas for improvement. Company Health Check FAQs
Health Rating1.5out of 5
0 Strong
4 Regular
8 Weak
Size
annual sales of £2m, make it smaller than the average company (£14m)
£2m - Pharma Medico Limited
£14m - Industry AVG
Growth
3 year (CAGR) sales growth of -7%, show it is growing at a slower rate (5.4%)
-7% - Pharma Medico Limited
5.4% - Industry AVG
Production
with a gross margin of 36.4%, this company has a comparable cost of product (36.4%)
36.4% - Pharma Medico Limited
36.4% - Industry AVG
Profitability
an operating margin of 3.4% make it as profitable than the average company (3.5%)
3.4% - Pharma Medico Limited
3.5% - Industry AVG
Employees
with 6 employees, this is below the industry average (31)
6 - Pharma Medico Limited
31 - Industry AVG
Pay Structure
on an average salary of £52.8k, the company has an equivalent pay structure (£52.8k)
£52.8k - Pharma Medico Limited
£52.8k - Industry AVG
Efficiency
resulting in sales per employee of £340.9k, this is equally as efficient (£375.2k)
£340.9k - Pharma Medico Limited
£375.2k - Industry AVG
Debtor Days
it gets paid by customers after 68 days, this is later than average (45 days)
68 days - Pharma Medico Limited
45 days - Industry AVG
Creditor Days
its suppliers are paid after 20 days, this is quicker than average (33 days)
20 days - Pharma Medico Limited
33 days - Industry AVG
Stock Days
it holds stock equivalent to 151 days, this is more than average (87 days)
151 days - Pharma Medico Limited
87 days - Industry AVG
Cash Balance
has cash to cover current liabilities
for 1 weeks, this is less cash available to meet short term requirements (14 weeks)
1 weeks - Pharma Medico Limited
14 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 98.5%, this is a higher level of debt than the average (61.1%)
98.5% - Pharma Medico Limited
61.1% - Industry AVG
PHARMA MEDICO LIMITED financials
EXPORT
Pharma Medico Limited's latest turnover from December 2023 is estimated at £2 million and the company has net assets of £14.5 thousand. According to their latest financial statements, Pharma Medico Limited has 6 employees and maintains cash reserves of £25.8 thousand as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Turnover
2,045,296
2,448,060
2,306,502
2,521,691
2,928,823
2,616,964
2,559,058
2,552,287
2,280,478
2,504,831
1,748,712
Other Income Or Grants
Cost Of Sales
1,300,027
1,551,545
1,461,189
1,521,104
1,823,396
1,645,711
1,698,965
1,670,415
1,452,235
1,740,677
1,136,769
Gross Profit
745,270
896,515
845,313
1,000,587
1,105,427
971,253
860,093
881,872
828,243
764,154
611,943
Admin Expenses
676,099
952,007
898,546
913,675
1,076,462
964,607
834,025
907,291
905,690
777,391
568,850
Operating Profit
69,171
-55,492
-53,233
86,912
28,965
6,646
26,068
-25,419
-77,447
-13,237
43,093
Interest Payable
18
6
3
Interest Receivable
3,408
1,919
25
10
4
Pre-Tax Profit
72,579
-53,573
-53,208
86,912
28,947
6,646
26,068
-25,425
-77,446
-13,237
40,753
Tax
-18,145
682
-682
-7,417
Profit After Tax
54,434
-53,573
-53,208
86,912
28,947
6,646
26,068
-25,425
-76,764
-13,919
33,336
Dividends Paid
Retained Profit
54,434
-53,573
-53,208
86,912
28,947
6,646
26,068
-25,425
-76,764
-13,919
33,336
Employee Costs
317,100
300,361
285,504
294,775
309,124
308,734
259,218
245,757
179,276
135,508
68,903
Number Of Employees
6
6
6
7
7
7
6
6
5
4
2
EBITDA*
71,488
-53,101
-50,419
88,980
31,221
8,639
30,516
-930
4,377
-10,757
44,932
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Tangible Assets
13,127
13,553
15,944
11,717
12,785
11,295
12,587
14,811
17,424
14,037
5,515
Intangible Assets
21,875
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
13,127
13,553
15,944
11,717
12,785
11,295
12,587
14,811
39,299
14,037
5,515
Stock & work in progress
539,721
489,505
522,384
997,636
567,486
638,610
525,829
446,227
363,064
412,661
315,382
Trade Debtors
384,205
521,667
454,344
589,232
685,703
681,428
703,929
826,008
583,234
594,215
564,073
Group Debtors
Misc Debtors
18,654
18,508
22,295
29,414
37,779
22,706
23,099
16,049
16,170
3,418
Cash
25,834
104,001
5,672
14,196
8,206
2,682
28,571
3,217
19,598
80,217
misc current assets
total current assets
968,414
1,133,681
1,004,695
1,630,478
1,299,174
1,373,196
1,252,464
1,323,905
965,564
1,042,644
963,090
total assets
981,541
1,147,234
1,020,639
1,642,195
1,311,959
1,384,491
1,265,051
1,338,716
1,004,863
1,056,681
968,605
Bank overdraft
4,125
Bank loan
Trade Creditors
72,170
62,731
106,976
108,189
133,817
229,317
108,898
96,080
1,061,210
97,202
47,338
Group/Directors Accounts
768,072
941,449
759,849
1,195,482
1,045,308
1,060,913
1,131,446
773,183
724,738
other short term finances
1,060,962
hp & lease commitments
other current liabilities
126,845
183,034
140,221
271,723
152,945
146,819
192,962
165,197
162,193
total current liabilities
967,087
1,187,214
1,007,046
1,575,394
1,332,070
1,433,549
1,320,755
1,420,488
1,061,210
1,035,582
934,269
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
682
total long term liabilities
682
total liabilities
967,087
1,187,214
1,007,046
1,575,394
1,332,070
1,433,549
1,320,755
1,420,488
1,061,210
1,036,264
934,269
net assets
14,454
-39,980
13,593
66,801
-20,111
-49,058
-55,704
-81,772
-56,347
20,417
34,336
total shareholders funds
14,454
-39,980
13,593
66,801
-20,111
-49,058
-55,704
-81,772
-56,347
20,417
34,336
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Operating Activities
Operating Profit
69,171
-55,492
-53,233
86,912
28,965
6,646
26,068
-25,419
-77,447
-13,237
43,093
Depreciation
2,317
2,391
2,814
2,068
2,256
1,993
2,224
2,614
3,074
2,480
1,839
Amortisation
2,224
21,875
78,750
Tax
-18,145
682
-682
-7,417
Stock
50,216
-32,879
-475,252
430,150
-71,124
112,781
79,602
83,163
-49,597
97,279
315,382
Debtors
-137,316
63,536
-142,007
-104,836
42,054
-45,207
-122,472
249,824
-11,102
42,894
567,491
Creditors
9,439
-44,245
-1,213
-25,628
-95,500
120,419
12,818
-965,130
964,008
49,864
47,338
Accruals and Deferred Income
-56,189
42,813
-131,502
118,778
152,945
-146,819
-46,143
192,962
-165,197
3,004
162,193
Deferred Taxes & Provisions
-682
682
Cash flow from operations
93,693
-85,190
434,125
-143,184
117,736
-85,335
40,061
-1,106,085
863,887
-98,062
-635,827
Investing Activities
capital expenditure
-1,891
-7,041
-1,000
-3,746
-701
-2,224
-1
-107,086
-11,002
-7,354
Change in Investments
cash flow from investments
-1,891
-7,041
-1,000
-3,746
-701
-2,224
-1
-107,086
-11,002
-7,354
Financing Activities
Bank loans
Group/Directors Accounts
-173,377
181,600
-435,633
150,174
1,045,308
-1,060,913
-70,533
1,131,446
-773,183
48,445
724,738
Other Short Term Loans
-1,060,962
1,060,962
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
1,000
interest
3,408
1,919
25
-18
10
-6
1
cash flow from financing
-169,969
183,519
-435,608
150,174
-15,672
59
-70,533
1,131,440
-773,182
48,445
725,738
cash and cash equivalents
cash
-78,167
98,329
-8,524
5,990
5,524
2,682
-28,571
25,354
-16,381
-60,619
80,217
overdraft
-4,125
4,125
change in cash
-78,167
98,329
-8,524
5,990
5,524
6,807
-32,696
25,354
-16,381
-60,619
80,217
pharma medico limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for pharma medico limited. Get real-time insights into pharma medico limited's credit score, group structure and payment trends.
Perform a competitor analysis for pharma medico limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in BS1 area or any other competitors across 12 key performance metrics.
pharma medico limited Ownership
PHARMA MEDICO LIMITED group structure
Pharma Medico Limited has no subsidiary companies.
The sole shareholder of Pharma Medico Limited is Pharma Medico Uk Ltd.
pharma medico uk ltd
100%
pharma medico limited directors
Pharma Medico Limited currently has 2 directors.
The longest serving directors include
Mr Christopher Keeble (Jan 2013) and
Mr Geoffrey Cleall-Harding (Jan 2013).
47910 - Retail sale via mail order houses or via Internet
46460 - Wholesale of pharmaceutical goods
incorporation date
January 2013
age
12
incorporated
UK
ultimate parent company
PHARMA MEDICO HOLDINGS LTD
accounts
Small Company
last accounts submitted
December 2023
previous names
N/A
accountant
RSM UK AUDIT LLP
auditor
-
address
first floor templeback, 10 temple back, bristol, BS1 6FL
Bank
-
Legal Advisor
-
pharma medico limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to pharma medico limited.
pharma medico limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for PHARMA MEDICO LIMITED. This can take several minutes, an email will notify you when this has completed.
pharma medico limitedCompanies House Filings - See Documents
